TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/09/2025
Voltar para busca
Dado oficial do USPTO
CHROMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
11/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 42
Data de depósito
02/08/2023
Data de registro
12/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/11/2024
Última transação
11/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
15/11/2023
Primeiro uso no comércio
15/11/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
Somerville, MA
Examinador
GUROK, GALINA
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Generate Biomedicines, Inc.
Generate Biomedicines, Inc.
Representantes
Jennifer M. Mikulina McDermott Will & Schulte LLP
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software for use in the pharmaceuticals and healthcare fieldsfor molecular researchresearch and development of pharmaceutical products and chemical compoundsdesign of chemical structuresanalysis of biological or chemical activity; downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields for molecular researchresearch and development of pharmaceutical products and chemical compoundsdesign of chemical structuresanalysis of biological or chemical activity in connection with pharmaceutical drug discovery and development; downloadable artificial intelligence software for use in the field of healthcare for molecular researchresearch and development of pharmaceutical products and chemical compoundsdesign of chemical structuresanalysis of biological or chemical activity
Classe 42
Researchdevelopmentdesign of pharmaceuticals and medicines for others; scientific research in the field of pharmaceutical and medicine designdiscovery and development services for others; research and development of technology for others in the field of pharmaceuticals; research and development of technology for others in the field of computational biology; pharmaceuticalmedicalscientificbiotechnologybiopharmaceutical research and development for others; collecting and analyzing complex biological data through the use of artificial intelligencedata automation and collection service using proprietary software to evaluateanalyze and collect biological data; computer assisted molecule design involving the use of artificial intelligence technologyproduct design and development in the field of medicine; conducting scientific and pharmaceutical artificial intelligence research services for others to identify molecules and compounds for drug developmentscientific research in the field of pharmaceuticals; providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fieldsfor molecular researchresearch and development of pharmaceutical products and chemical compoundscell analysisdesign of chemical structuresanalysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fieldsfor diagnostic and therapeutic usefor data mining in connection with pharmaceutical drug discoverydrug developmentpharmaceutical market accesschemogenomicstoxicogenomics and drug response prediction; providing online non-downloadable self-learning and artificial intelligence software for use in the field of healthcare for molecular researchresearch and development of pharmaceutical products and chemical compoundscell analysisdesign of chemical structuresanalysis of biological or chemical activity; providing online non-downloadable software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/09/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/02/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/08/2024
PUBO
PUBLISHED FOR OPPOSITION
27/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2024
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
11/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/04/2024
GNRT
NON-FINAL ACTION E-MAILED
10/04/2024
CNRT
NON-FINAL ACTION WRITTEN
10/04/2024
IUAA
USE AMENDMENT ACCEPTED
10/04/2024
DOCK
ASSIGNED TO EXAMINER
03/04/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
12/12/2023
IUAF
USE AMENDMENT FILED
12/12/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
11/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/08/2023
NWAP
NEW APPLICATION ENTERED
05/08/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CHROMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.